Stock screenerAll disclosures →
EDGAR →
MRNA
Conviction 80HealthcareScan · Tue, Sep 8, 2026Three outside down
MRNA$140.33-3.59%
ResistanceSupportVol 14Insider sellCongress buyCongress sell4
Vol MA14 45.72M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
WSB mentions · 24h changelatest +100.00%· 2 mentions
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Price140.33
Change-3.59%
Gap+0.14%
Rel volume0.33×
Avg volume33.72M
Avg $ vol5.01B
SMA 20121.99
SMA 5086.96
SMA 20055.40
Price vs 50+61.37%
Price vs 200+153.29%
MA stackbullish
50/200 cross—
Supertrendup · 105.02
RSI (14)61
MACD hist-0.42
MACD crossbear · 0d
Stoch %K / %D42 / 63
ADX (14)53
+DI / −DI40 / 9
RSI divergence—
MACD divergence—
ATR %+9.45%
ADR %9.50%
52w high174.38
52w low22.36
From 52w high-19.53%
Above 52w low+527.57%
New 52w highNo
SqueezeOff
Bollinger width129.39%
%B0.62
Donchian pos69.22%
Donchian high176.66
Donchian low58.60
AVWAP (52w high)147.66
vs AVWAP high-4.97%
AVWAP (52w low)76.22
vs AVWAP low+84.11%
OBV trendUp
Chaikin MF (20)0.29
Today vs 20d0.33×
Avg vol (14d)45.72M
Avg vol (20d)33.72M
Avg $ vol (20d)5.01B
Market cap56.02B
RS 3m (vs SPY)+202.38%
RS 6m (vs SPY)+162.59%
RS line new highNo
Trend template8/8
Technical rank92.7
1 week-0.01%
1 month+137.16%
3 months+194.80%
6 months+151.75%
1 year+458.17%
YTD+354.71%
P/E-19.85
P/B8.29
P/S28.82
P/FCF-27.13
EPS-7.26
Div yield—
ROE-41.74%
ROA-25.75%
Debt/Eq0.09
Current2.29
EV/EBITDA-19.17
Gross margin—
Net margin-145.16%
Rev growth-39.93%
EPS growth20.75%
Price target96.60
Target upside-31.16%
Analyst ratingHold
Institutional92.33%
Ent. value54.89B
Revenue145M
Net income-782M
Gross profit—
Free cash flow-2.06B
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out396.79M
Employees4.7K
ListedFri, Dec 7, 2018
Free float361.08M
Float %91.0%
Short interest52.81M
Days to cover9.2d
Short volume53.6%
Squeeze score63 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$1.97 vs −$1.97
Last surprise0.0% beat
Setup gradeA
Conviction80 / 100
Pattern quality—
Tech rank92.7 / 100
Group rank96 / 100 · Leading
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmThree outside down
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- GSK's mRNA flu vaccine data closely tracks Moderna's, Deutsche Bank saysProactiveinvestors · Fri, Sep 4, 2026
- 3 Inflated Stocks with Open QuestionsYahoo Finance · Fri, Sep 4, 2026
Congress activity
Disclosed STOCK Act trades in MRNA · 3 recent
Insider activity
SEC Form 4 transactions in MRNA · 4 buys · 6 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Klinger Shannon Thyme Chief Legal Officer · Common Stock · 2026-08-28 | Tax | 160 | $23K | 2026-08-28 | 2026-08-31 |
Hoge Stephen President · Restricted Stock Units · 2026-08-28 | Exercise | 611 | — | 2026-08-28 | 2026-08-31 |
Klinger Shannon Thyme Chief Legal Officer · Restricted Stock Units · 2026-08-28 | Exercise | 329 | — | 2026-08-28 | 2026-08-31 |
Hoge Stephen President · Common Stock · 2026-08-28 | Tax | 296 | $42K | 2026-08-28 | 2026-08-31 |
Hoge Stephen President · Common Stock · 2026-08-28 | Exercise | 611 | — | 2026-08-28 | 2026-08-31 |
Mock James M Chief Financial Officer · Common Stock · 2026-08-28 | Exercise | 329 | — | 2026-08-28 | 2026-08-31 |
Mock James M Chief Financial Officer · Common Stock · 2026-08-28 | Tax | 160 | $23K | 2026-08-28 | 2026-08-31 |
Klinger Shannon Thyme Chief Legal Officer · Common Stock · 2026-08-28 | Exercise | 329 | — | 2026-08-28 | 2026-08-31 |
Mock James M Chief Financial Officer · Restricted Stock Units · 2026-08-28 | Exercise | 329 | — | 2026-08-28 | 2026-08-31 |
Hoge Stephen President · Common Stock · 2026-08-27 | Exercise | 1.44K | — | 2026-08-27 | 2026-08-31 |
SEC filings
EDGAR filings in MRNA · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.